Picture of EQL Pharma AB logo

EQL — EQL Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
Consumer DefensivesSpeculativeSmall CapNeutral

Brief: EQL Pharma Reports Group's Sales During Q1 Amounted To SEK 37.3 (99.5) Mln

Aug 16 (Reuters) - EQL Pharma AB  EQL.TE :
    * EARNINGS PER SHARE WERE SEK 0:09 (0:39) FOR QUARTER
    * GROUP'S SALES DURING Q1 AMOUNTED TO SEK 37.3 (99.5)
MILLION
    * IN JULY, EMANUEL ERIKSSON TOOK OVER AS NEW CFO
    * DURING QUARTER, CO DECIDED TO POSTPONE ANNOUNCED LIST
CHANGE
FROM SPOTLIGHT NEXT TO NASDAQ STOCKHOLM'S MAIN MARKET


Further company coverage:  EQL.TE 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on EQL Pharma AB

See all news